Cleared Traditional

K181372 - Argos

K181372 is an FDA 510(k) clearance for Argos, manufactured by Retia Medical, LLC. The device is a Class 2 Cardiovascular device with product code DXG cleared through the Traditional 510(k) pathway after a 204-day FDA review.

K181372 · Retia Medical, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
204d
Days
Class 2
Risk

K181372 is an FDA 510(k) clearance for the Argos. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Retia Medical, LLC (Valhalla, US). The FDA issued a Cleared decision on December 13, 2018 after a review of 204 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Retia Medical, LLC devices

FDA 510(k) Submission Details - K181372

510(k) Number K181372 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2018
Decision Date December 13, 2018
Days to Decision 204 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
79d slower than avg
Panel avg: 125d · This submission: 204d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXG Device Classification - Class 2, Special Controls

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 107
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K181372.
PulsioFlex Monitoring System with ProAQT Sensor
K192169 · Pulsion Medical Systems SE · Apr 2020
EV1000 Clinical Platform
K193179 · Edwards Lifesciences, LLC · Dec 2019
Hypotension Decision Assist
K190955 · Directed Systems, Ltd. · Nov 2019
PulsioFlex Monitoring System
K172259 · Pulsion Medical Systems SE · Jan 2018
LiDCOunity v2 Hemodynamic Monitor
K163334 · Lidco, Ltd. · Jun 2017
LiDCOunity Monitor
K152935 · Lidco, Ltd. · Mar 2016